{"id":"https://openalex.org/W4287984366","doi":"https://doi.org/10.29011/2574-7568.010102","title":"Efficacy and Safety of Fixed-dose Combination of Teneligliptin and Pioglitazone versus Respective Monotherapies in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Phase III Randomized Parallel Group Study","display_name":"Efficacy and Safety of Fixed-dose Combination of Teneligliptin and Pioglitazone versus Respective Monotherapies in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Phase III Randomized Parallel Group Study","publication_year":2022,"publication_date":"2022-07-16","ids":{"openalex":"https://openalex.org/W4287984366","doi":"https://doi.org/10.29011/2574-7568.010102"},"language":"en","primary_location":{"id":"doi:10.29011/2574-7568.010102","doi":"https://doi.org/10.29011/2574-7568.010102","is_oa":true,"landing_page_url":"https://doi.org/10.29011/2574-7568.010102","pdf_url":"https://www.gavinpublishers.com/assets/articles_pdf/Efficacy-and-Safety-of-Fixed-dose-Combination-of-Teneligliptin-and-Pioglitazone-versus-Respective-Monotherapies-in-Patients-with-Type-2-Diabetes-Mellitus-Inadequately-Controlled-on-Metformin-A-Phase-III-Randomized-Parallel-Group-Study.pdf","source":{"id":"https://openalex.org/S4210234967","display_name":"Journal of Diabetes and Treatment","issn_l":"2574-7568","issn":["2574-7568"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.gavinpublishers.com/assets/articles_pdf/Efficacy-and-Safety-of-Fixed-dose-Combination-of-Teneligliptin-and-Pioglitazone-versus-Respective-Monotherapies-in-Patients-with-Type-2-Diabetes-Mellitus-Inadequately-Controlled-on-Metformin-A-Phase-III-Randomized-Parallel-Group-Study.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"A Gopal Rao, Richa Giri, Sanjiv Maheshwari, Vibhuti Jadhao, Sachin Suryawanshi, Hanmant Barkate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800401362","display_name":"Government of Andhra Pradesh","ror":"https://ror.org/045mrnd19","country_code":"IN","type":"government","lineage":["https://openalex.org/I2800401362"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"A Gopal Rao, Richa Giri, Sanjiv Maheshwari, Vibhuti Jadhao, Sachin Suryawanshi, Hanmant Barkate","raw_affiliation_strings":["Government Medical College & Government General Hospital (Old RIMSGGH), Srikakulam, Andhra Pradesh"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Government Medical College & Government General Hospital (Old RIMSGGH), Srikakulam, Andhra Pradesh","institution_ids":["https://openalex.org/I2800401362"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800401362"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.12968986,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"7","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/teneligliptin","display_name":"teneligliptin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.9929999709129333},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9860000014305115},{"id":"https://openalex.org/keywords/inadequate-glycemic-control","display_name":"inadequate glycemic control","score":0.6819999814033508},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7979999780654907},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.871999979019165},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.8769999742507935},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.925000011920929},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8930000066757202}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.8654263615608215},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8523300886154175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7502378225326538},{"id":"https://openalex.org/C2776623344","wikidata":"https://www.wikidata.org/wiki/Q5456317","display_name":"Fixed-dose combination","level":2,"score":0.696459949016571},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.696050763130188},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5523322224617004},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5489512085914612},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.45854759216308594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42067140340805054},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3851180970668793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35981041193008423},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2592426538467407}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.29011/2574-7568.010102","doi":"https://doi.org/10.29011/2574-7568.010102","is_oa":true,"landing_page_url":"https://doi.org/10.29011/2574-7568.010102","pdf_url":"https://www.gavinpublishers.com/assets/articles_pdf/Efficacy-and-Safety-of-Fixed-dose-Combination-of-Teneligliptin-and-Pioglitazone-versus-Respective-Monotherapies-in-Patients-with-Type-2-Diabetes-Mellitus-Inadequately-Controlled-on-Metformin-A-Phase-III-Randomized-Parallel-Group-Study.pdf","source":{"id":"https://openalex.org/S4210234967","display_name":"Journal of Diabetes and Treatment","issn_l":"2574-7568","issn":["2574-7568"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes and Treatment","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.29011/2574-7568.010102","doi":"https://doi.org/10.29011/2574-7568.010102","is_oa":true,"landing_page_url":"https://doi.org/10.29011/2574-7568.010102","pdf_url":"https://www.gavinpublishers.com/assets/articles_pdf/Efficacy-and-Safety-of-Fixed-dose-Combination-of-Teneligliptin-and-Pioglitazone-versus-Respective-Monotherapies-in-Patients-with-Type-2-Diabetes-Mellitus-Inadequately-Controlled-on-Metformin-A-Phase-III-Randomized-Parallel-Group-Study.pdf","source":{"id":"https://openalex.org/S4210234967","display_name":"Journal of Diabetes and Treatment","issn_l":"2574-7568","issn":["2574-7568"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes and Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4287984366.pdf","grobid_xml":"https://content.openalex.org/works/W4287984366.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W131211302","https://openalex.org/W1561779083","https://openalex.org/W1799193569","https://openalex.org/W1824359486","https://openalex.org/W1977574777","https://openalex.org/W2004627568","https://openalex.org/W2136387838","https://openalex.org/W2143674095","https://openalex.org/W2146466098","https://openalex.org/W2146581079","https://openalex.org/W2150042949","https://openalex.org/W2508300559","https://openalex.org/W2522970985","https://openalex.org/W2789732774","https://openalex.org/W2810387891","https://openalex.org/W3016341131","https://openalex.org/W3048569335","https://openalex.org/W4200358162","https://openalex.org/W4214949543","https://openalex.org/W4230464792"],"related_works":["https://openalex.org/W7104048111","https://openalex.org/W2941603697","https://openalex.org/W7171858552","https://openalex.org/W2026669955","https://openalex.org/W4386392090","https://openalex.org/W4388646450","https://openalex.org/W2522970985","https://openalex.org/W6930736511","https://openalex.org/W7121106096","https://openalex.org/W2744768807"],"abstract_inverted_index":{"Background":[0],"and":[1,34,57,69,81,132,164,214,220,231,235,246],"aims:":[2],"Teneligliptin,":[3],"a":[4,16,36],"third":[5],"generation":[6],"DPP-4":[7],"inhibitor,":[8],"decreases":[9],"the":[10,21,55,111,179,223,247],"degradation":[11],"of":[12,27,59,61,71,124,181,217,225,229],"incretins,":[13],"while":[14,209],"Pioglitazone,":[15],"potent":[17],"insulin":[18],"sensitizer,":[19],"reduces":[20],"glucose":[22],"output":[23],"from":[24,103,115,148],"liver.A":[25],"combination":[26,248],"these":[28],"two":[29],"could":[30],"be":[31],"beneficial":[32],"clinically;":[33],"hence":[35],"comparative":[37],"study":[38,50],"was":[39,51,110,120,190,249],"planned.Methods:":[40],"A":[41],"prospective,":[42],"randomized,":[43],"double":[44],"blind,":[45],"comparative,":[46],"parallel":[47],"group":[48],"multicentre":[49],"planned":[52],"to":[53,117,146,150,174,197,243],"evaluate":[54],"safety":[56],"efficacy":[58],"FDC":[60,70,142,171,193,228],"Teneligliptin":[62,72,79],"20mg":[63,73,80],"+":[64,74],"Pioglitazone":[65,75,82],"15":[66],"mg":[67],"tablets":[68,77],"30mg":[76,83],"versus":[78],"alone":[84],"in":[85,100,113,122,141,170,192,203],"patients":[86,97,182],"with":[87],"type":[88],"2":[89],"diabetes":[90],"mellitus":[91],"(T2DM),":[92],"inadequately":[93],"controlled":[94],"on":[95,130,206,211,238],"Metformin.Eight-six":[96],"were":[98,128,201,216],"recruited":[99],"each":[101],"arm":[102],"fifteen":[104],"centres":[105],"across":[106],"India.The":[107],"primary":[108],"endpoint":[109,135],"change":[112,140,169],"HbA1c":[114,136,184],"baseline":[116,149],"week":[118,151,156,188],"24.Safety":[119],"assessed":[121],"terms":[123],"hypoglycaemic":[125],"episodes.Results:":[126],"Patients":[127],"matched":[129],"demographic":[131],"anthropometric":[133],"parameters.Primary":[134],"showed":[137,166],"significantly":[138,167],"more":[139,168],"groups":[143,194],"as":[144,153,155,172,195,241],"compared":[145,173,196,242],"monotherapies":[147,175,245],"12,":[152],"well":[154,250],"24":[157,189],"(p":[158,176],"<":[159,177,185],"0.0001).On":[160],"similar":[161],"lines,":[162],"FBG":[163],"PPBG":[165],"0.0001).Moreover,":[178],"proportion":[180],"achieving":[183],"7%":[186],"by":[187,222],"higher":[191],"monotherapy":[198,213],"groups.Hypoglycaemic":[199],"episodes":[200],"observed":[202],"3.48%":[204],"cases":[205],"dual":[207],"therapy,":[208],"1.74%":[210],"pioglitazone":[212,232],"all":[215],"mild":[218],"severity":[219],"resolved":[221],"end":[224],"study.Conclusion:":[226],"The":[227],"teneligliptin":[230],"has":[233],"superior":[234],"significant":[236],"control":[237],"glycaemic":[239],"parameters":[240],"respective":[244],"tolerated.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-07-26T00:00:00"}